Exelixis (EXEL) Cash from Investing Activities (2010 - 2026)

Exelixis (EXEL) recorded quarterly Cash from Investing Activities of -$51.1 million in Q2 2026, down 287.47% quarter-over-quarter from $27.2 million in Q1 2026, and down 202.62% on a YoY basis from $49.8 million in Q2 2025.

Exelixis (EXEL) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Exelixis' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$51.1 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 202.62% year-over-year to -$51.1 million; the TTM figure through Apr 2026 stood at $249.6 million (up 239.59% YoY), while the FY2026 annual figure was $350.4 million, up 400.08% from the prior year.
  • Cash from Investing Activities was -$51.1 million for Q2 2026 at Exelixis, down from $27.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $248.0 million in Q3 2025 to a low of -$245.8 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$21.7 million across 5 years, with a median of -$49.6 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities tumbled 1782.67% in 2022, then jumped 325.43% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$245.8 million in 2022, then surged by 125.12% to $61.7 million in 2023, then tumbled by 451.73% to -$217.1 million in 2024, then jumped by 111.7% to $25.4 million in 2025, then tumbled by 301.02% to -$51.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$51.1 million (Q2 2026), $27.2 million (Q1 2026), and $25.4 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.89 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 579,519.10
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn -51.07 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -51.07 Mn
Apr 3, 2026 -51.07 Mn
Jan 2, 2026 27.24 Mn
Jan 2, 2026 27.24 Mn
Oct 3, 2025 25.41 Mn
Oct 3, 2025 25.41 Mn
Jul 4, 2025 248.03 Mn
Jul 4, 2025 248.03 Mn
Apr 4, 2025 49.76 Mn
Apr 4, 2025 49.76 Mn
Jan 3, 2025 -93.20 Mn
Jan 3, 2025 -93.20 Mn
Sep 27, 2024 -217.15 Mn
Sep 27, 2024 -217.15 Mn
Jun 28, 2024 81.77 Mn
Jun 28, 2024 81.77 Mn
Mar 29, 2024 111.79 Mn
Mar 29, 2024 111.79 Mn
Dec 29, 2023 61.74 Mn
Dec 29, 2023 61.74 Mn